
Glimimed M 2mg/500mg Tablet SR
Marketer
Medmom Pharmaceuticals LLP
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Glimimed M 2mg/500mg Tablet SR
Diabexe Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose control. Diabexe Duo should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Glimimed M 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimimed M 2mg/500mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimimed M 2mg/500mg Sustained-Release Tablets with food.
Common Side effects of Glimimed M 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimimed M 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimimed M 2mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
How Glimimed M 2mg/500mg Tablet SR works:
Glimimed M 2mg/500mg Extended-Release Tablets contain glimepiride and metformin, two agents that manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Glimimed M 2mg/500mg SR tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glimimed M 2mg/500mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. Prescribing will involve a physician's assessment of benefits versus potential hazards. Seek medical advice.
Breast feedingUNSAFE
Extended-release Glimimed M tablets (2mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glimimed M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimimed M 2mg/500mg SR tablets. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimimed M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; however, Glimimed M 2mg/500mg SR tablets are contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Glimimed M 2mg/500mg Tablet SR :
Should you forget a dose of your Glimimed M 2mg/500mg SR tablet, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimimed M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
